Skip to main content

Table 2 Medications with decreased consumption found in the number of people in the DG

From: Improvement in prescriptions while maintaining overall health outcomes: a prospective observational study conducted in Japanese facilities for older people

  Number of people taking medications Difference Percentage
Generic name A. 2019 B. 2020 C. A-B C/A
Magnesium Oxide a 170 118 52 30.6%
Levamipide 38 6 32 84.2%
Amlodipine Besil 118 88 30 25.4%
Heparinoid 49 20 29 59.2%
Loxoprofen a 36 16 20 55.6%
Ketoprofen a 30 11 19 63.3%
Dimethylisopropyl azulene 29 11 18 62.1%
Sennoside 72 54 18 25.0%
White Vaseline 31 13 18 58.1%
Ambroxol 22 5 17 77.3%
Acetaminophen 41 26 15 36.6%
Donepezil 53 39 14 26.4%
Famotidine a 23 9 14 60.9%
Betamethasone butyrate propionate 18 4 14 77.8%
Mosapride 19 5 14 73.7%
  1. a Generic name listed in the “Guidelines for medical treatment and its safety in the older people 2015”
  2. DG (decrement group), the participants whose number of medications decreased during the study period (between March 2019 and March 2020)